These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11534536)

  • 1. The changing effector pattern of tardive dyskinesia during the course of neuroleptic withdrawal.
    Newell KM; Wszola B; Sprague RL; Mahorney SL; Bodfish JW
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):262-8. PubMed ID: 11534536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of dyskinesia and changes in postural task performance during the course of neuroleptic withdrawal.
    Newell KM; Ko YG; Sprague RL; Mahorney SL; Bodfish JW
    Am J Ment Retard; 2002 Jul; 107(4):270-7. PubMed ID: 12069646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of lip dyskinesia associated with neuroleptic withdrawal.
    Newell KM; Bodfish JW; Mahorney SL; Sprague RL
    Am J Ment Retard; 2000 Jul; 105(4):260-8. PubMed ID: 10934568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
    Apud JA; Egan MF; Wyatt RJ
    Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia in young mentally retarded individuals.
    Gualtieri CT; Schroeder SR; Hicks RE; Quade D
    Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia and the behavioral consequences of chronic neuroleptic treatment.
    Gualtieri CT; Guimond M
    Dev Med Child Neurol; 1981 Apr; 23(2):255-9. PubMed ID: 6111511
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reversibility of "permanent" tardive dyskinesia.
    Klawans HL; Tanner CM; Barr A
    Clin Neuropharmacol; 1984; 7(2):153-9. PubMed ID: 6145520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design.
    Dixon L; Thaker G; Conley R; Ross D; Cascella N; Tamminga C
    Schizophr Res; 1993 Oct; 10(3):267-71. PubMed ID: 8260445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic medication facilitates the natural occurrence of tardive dyskinesia. A critical review.
    Driesens F
    Acta Psychiatr Belg; 1988; 88(3):195-205. PubMed ID: 2906780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of tardive dyskinesia.
    Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prediction of chronic persistent versus intermittent tardive dyskinesia. A retrospective follow-up study.
    Glazer WM; Morgenstern H; Doucette JT
    Br J Psychiatry; 1991 Jun; 158():822-8. PubMed ID: 1678663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early course of new-onset tardive dyskinesia in older patients.
    Lacro JP; Gilbert PL; Paulsen JS; Fell R; Bailey A; Juels C; Caligiuri M; McAdams LA; Harris MJ; Jeste DV
    Psychopharmacol Bull; 1994; 30(2):187-91. PubMed ID: 7831454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA; Haugland G; Craig TJ
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.